$PFE: Here’s Why Sangamo Therapeutics Inc. Fell 25.3% in October

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Motley Fool (https://www.fool.com)

Summary: The Nasdaq Biotechnology Index fell 13.9%, and companies like Sangamo that don’t … with SB-525, a hemophilia candidate partnered with Pfizer (NYSE:PFE).

Full article address: https://www.fool.com/investing/2018/11/10/heres-why-sangamo-therapeutics-inc-fell-253-in-oct.aspx

Related News:

$BIIB $PFE $JNJ $LLY $MRK: Failed Alzheimer’s trial leaves families and patients heartbroken. Medical community reels

$PFE $AERI $AITB $ASRT: Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan

$JPM $SPGI $PFE $BA $AAPL: Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order

$PFE: Pfizer buys stake in French gene company in deal worth up to $636M

$BMY $AZN $MRK $PFE: Merck’s Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market

$PFE $SGMO: Why Pfizer Is Getting Deeper Into Gene Therapy

$CSCO $PFE: 5 of the Best Dow Jones Stocks to Buy for Solid Dividends

$AGN $XPH $PFE: Allergan Stock Won’t Benefit From a Breakup, Analyst Says

$PFE: Pfizer Moves Over Half a Billion for Wilson Disease Treatment

$PFE $MRK $BMY $MKGAF: Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study

$PFE $NVS $AGN $CNAT: Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan

Latest News:

$DWDP: Is DowDuPont a Buy?

$T $VIA: Viacom and AT&T Negotiate to Avert Major Programming Blackout

$MGM $CZR $VICI: How Wynn Resorts Could Free Up Billions in Cash

$PYX $RKDA: CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

$GE: 3 Stocks Looking to Benefit From GE’s Misfortunes

$LEVI: Before the Levi’s IPO, there was the 1985 buyout led by iconoclastic S.F. investor Warren Hellman

$TLRY $CGC: 1 Figure That Guarantees a Canadian Marijuana Oversupply Is …

$AAPL $GS: Steve Jobs was trying to revolutionize TV almost a decade ago — now we’ll find out Apple’s plan

$SBUX: Starbucks Increasing its Environmental Commitment

$GH $ROKU: 3 Stocks That Are Up More Than 100% in 2019

$SUN: Is Sunoco a Buy?